Erdafitnib Tablets 3 Mg

Details

Erdafitinib 3 mg Tablets (Erdanat-3)

Quantity

1 Box × 28 Film-Coated Tablets

Manufacturer

NATCO Pharma Ltd.

Category

Targeted Cancer Therapy (FGFR Inhibitor)

Indications

• Used for the treatment of locally advanced or metastatic urothelial carcinoma (bladder cancer) in patients with susceptible FGFR3 or FGFR2 genetic alterations, as prescribed by an oncologist.